Nan Li

Nan Li

Private Equity Investor bij RECURSION PHARMACEUTICALS, INC.

Technology Services
Health Technology
Finance

Profiel

Nan Li founded Dimension Management LP, where he worked as Managing Partner.
Mr. Li also currently works at LabGenius Ltd., as Director from 2019, Inato SAS, as Investor & Board Director from 2019, DarwinAI Corp., as Investor & Board Director from 2018, Dexterity, Inc. (California), as Investor & Board Director from 2017, Iterative Health, Inc., as Director from 2021, At Hatfield, Inc., as Board of director from 2017, Recursion Pharmaceuticals, Inc., as Investor & Board Observer from 2016, Planet Labs, Inc., as Investor from 2013, Zymergen, Inc., as Investor, Board Observer & Advisor from 2013, Tempo Automation, Inc., as Investor from 2015, Dyno Therapeutics, Inc., as Investor from 2018, Octave Health Group, Inc., as Investor & Board Observer from 2019, Swiftscale Biologics, Inc., as Investor & Board Observer from 2020, n8n GmbH, as Investor from 2019, and Anagenex, Inc., as Investor & Board Observer from 2020.
Mr. Li also formerly worked at Obvious Management Services LLC, as Managing Director from 2015 to 2022, Thorley Industries LLC, as Investor & Board Observer from 2011 to 2012, HookLogic, Inc., as Investor & Board Observer from 2010 to 2012, Formlabs, Inc., as Investor from 2013 to 2015, HumanAPI, Inc., as Investor from 2014 to 2015, Bain Capital Ventures LP, as Venture Capital Investor from 2010 to 2012, Bain & Co., Inc., as Principal from 2008 to 2010, Innovation Endeavors LLC, as Investment Partner from 2013 to 2015, Sandpiper Labs, Inc., as Head of Product, Operations & Finance from 2012 to 2013, Blue River Technology, Inc., as Investor & Board Observer from 2013 to 2015, TPR Education IP Holdings LLC, as Investor from 2011 to 2012, and Estimote, Inc., as Investor from 2013 to 2015.
Mr. Li received his undergraduate degree from the University of Michigan.

Actieve functies van Nan Li

BedrijvenFunctieBegin
RECURSION PHARMACEUTICALS, INC. Private Equity Investor 01-10-2016
ZYMERGEN INC. Consultant / Advisor 01-01-2013
Private Equity Investor 01-01-2013
Private Equity Investor 01-01-2015
Private Equity Investor 01-11-2018
Private Equity Investor 01-05-2019
Private Equity Investor 01-12-2019
Private Equity Investor 01-01-2020
Private Equity Investor 01-08-2020
░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Alle actieve functies van Nan Li

Eerdere bekende functies van Nan Li

BedrijvenFunctieEinde
░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
Ervaring van Nan Li in detail bekijken

Opleiding van Nan Li

University of Michigan Undergraduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Nan Li in detail bekijken

Connecties

100 +

Eerstegraads connecties

29

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven1
RECURSION PHARMACEUTICALS, INC.

Health Technology

Bedrijven in privébezit27

Consumer Durables

Technology Services

Producer Manufacturing

Technology Services

Finance

Commercial Services

Industrial Services

Finance

Technology Services

Commercial Services

Commercial Services

Technology Services

Finance

Commercial Services

Technology Services

Health Technology

Technology Services

Technology Services

Electronic Technology

Health Technology

Health Services

Technology Services

Health Technology

Technology Services

Technology Services

Consumer Services

Finance

Zie bedrijfsconnecties